Palumbo Wealth Management’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
Palumbo Wealth Management's DFTX Position: Q3 2026 in Review
Palumbo Wealth Management reduced its Definium Therapeutics (DFTX) stake by 39% in Q3 2026, selling an estimated $482K and leaving 17,844 shares worth $679K. The position accounts for 0.14% of the portfolio, ranked #103.
Palumbo Wealth Management first reported a position in DFTX in Q1 2025 and has held it in 7 quarters since. The position peaked at $1.38M in Q2 2026. 354 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- Palumbo Wealth Management held 17,844 shares of Definium Therapeutics worth $679K as of Q3 2026.
- Palumbo Wealth Management sold 11,443 Definium Therapeutics shares in Q3 2026, an estimated $482K.
- Definium Therapeutics made up 0.14% of Palumbo Wealth Management's portfolio in Q3 2026, its #103 holding.
- Palumbo Wealth Management first reported a position in Definium Therapeutics in Q1 2025 and has held it in 7 quarters since.
- Palumbo Wealth Management's Definium Therapeutics position peaked at $1.38M in Q2 2026.
- 354 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on Palumbo Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.